Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged (ABT) Income Statement
Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged Income Statement
Last quarter (Q3 2020), Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged's total revenue was $28.50M, an increase of 11.08% from the same quarter last year. In Q3, Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged's net income was $2.60M. See Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 20 | Jun 19 | Jun 18 |
|---|---|---|---|
| $ 104.67M | $ 98.91M | $ 93.62M | |
| $ 92.04M | $ 85.93M | $ 79.26M | |
| $ 76.78M | $ 75.03M | $ 76.38M | |
| Depreciation and Amortization | $ 5.32M | $ 3.42M | $ 12.40M |
| $ 21.18M | $ 14.53M | $ 15.26M | |
| $ 15.27M | $ 10.90M | $ 2.88M | |
| $ -24.50K | $ 209.09K | $ -18.52K | |
| $ 15.24M | $ 11.11M | $ 2.86M | |
| $ 10.63M | $ 7.58M | $ 3.11M | |
| Per Share Metrics | |||
| Basic EPS | $ 0.24 | $ 0.18 | $ 0.08 |
| Diluted EPS | $ 0.24 | $ 0.18 | $ 0.08 |
| Weighted Average Shares Outstanding | 44.75M | 42.11M | 40.03M |
| Weighted Average Shares Outstanding (Diluted) | 44.75M | 42.11M | 40.03M |
Currency in USD
